Open AccessThe Effect of Activated Factor VII for Intracerebral Hemorrhage Beyond 3 Hours Versus Within 3 Hours
Author(s) -
Hen Hallevi,
Nicole R. Gonzales,
Andrew D. Barreto,
Sheryl MartinSchild,
Karen C. Albright,
Elizabeth A. Noser,
Kachi Illoh,
Aslam M. Khaja,
Teresa A. Allison,
Miguel A. Escobar,
Hashem Shaltoni,
James C. Grotta
Publication year - 2008
Publication title -
stroke
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.397
H-Index - 319
eISSN - 1524-4628
pISSN - 0039-2499
DOI - 10.1161/strokeaha.107.497651
Subject(s) - medicine , intracerebral hemorrhage , adverse effect , anesthesia , surgery , subarachnoid hemorrhage
Recombinant-activated factor VII (rFVIIa) is an investigational treatment for intracerebral hemorrhage (ICH). We have evaluated the drug's treatment effect based on time to treatment.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom